Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study

Christina H. B. Ruhlmann; T B Christensen; L H  Dohn; M Paludan; E Rønnengart; F Hilbert; P Feyer; G Kristensen; D Keefe; Olfred Hansen; Jørn Herrstedt

Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study

Christina H. B. Ruhlmann
, T B Christensen
, L H Dohn
, M Paludan
, E Rønnengart
, F Hilbert
, P Feyer
, G Kristensen
, D Keefe
, Olfred Hansen
, Jørn Herrstedt

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	2015
Status	Udgivet - 2015
Begivenhed	European Cancer Congress (ECC) 2015 - Wien, Østrig Varighed: 25. sep. 2015 → 29. sep. 2015

Konference

Konference	European Cancer Congress (ECC) 2015
Land/Område	Østrig
By	Wien
Periode	25/09/2015 → 29/09/2015

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Ruhlmann, C. H. B., Christensen, T. B., Dohn, L. H., Paludan, M., Rønnengart, E., Hilbert, F., Feyer, P., Kristensen, G., Keefe, D., Hansen, O., & Herrstedt, J. (2015). Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study. Abstract fra European Cancer Congress (ECC) 2015, Wien, Østrig.

@conference{c5f5919af2ac45e29195fcf0868291d7,

title = "Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study",

author = "Ruhlmann, \{Christina H. B.\} and Christensen, \{T B\} and Dohn, \{L H\} and M Paludan and E R{\o}nnengart and F Hilbert and P Feyer and G Kristensen and D Keefe and Olfred Hansen and J{\o}rn Herrstedt",

year = "2015",

language = "English",

note = "European Cancer Congress (ECC) 2015 ; Conference date: 25-09-2015 Through 29-09-2015",

}

Ruhlmann, CHB, Christensen, TB, Dohn, LH, Paludan, M, Rønnengart, E, Hilbert, F, Feyer, P, Kristensen, G, Keefe, D, Hansen, O & Herrstedt, J 2015, 'Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study', European Cancer Congress (ECC) 2015, Wien, Østrig, 25/09/2015 - 29/09/2015.

Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study. / Ruhlmann, Christina H. B.; Christensen, T B; Dohn, L H et al.
2015. Abstract fra European Cancer Congress (ECC) 2015, Wien, Østrig.

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

TY - ABST

T1 - Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study

AU - Ruhlmann, Christina H. B.

AU - Christensen, T B

AU - Dohn, L H

AU - Paludan, M

AU - Rønnengart, E

AU - Hilbert, F

AU - Feyer, P

AU - Kristensen, G

AU - Keefe, D

AU - Hansen, Olfred

AU - Herrstedt, Jørn

PY - 2015

Y1 - 2015

M3 - Conference abstract for conference

T2 - European Cancer Congress (ECC) 2015

Y2 - 25 September 2015 through 29 September 2015

ER -